More

Jan 12- EMC said on Monday that activist investor Elliott Management Corp will vote for EMC's proposed directors as part of a standstill agreement with the data storage company prohibiting the hedge fund from agitating the company until September. Since October 2014, Elliott has been publicly pushing data storage maker EMC to spin off its VMware software...

Dec 4- The top U.S. patent appeals court has thrown out a $176 million award for healthcare company Covidien Plc in a dispute with a Johnson& Johnson subsidiary over surgical instruments. Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., ruled on Thursday that Covidien's patent claims, which involve surgical cutting tools...

WASHINGTON, Nov 26- Medtronic Inc has won U.S. antitrust approval to buy Dublin- based Covidien Plc on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday. Medtronic and Covidien shareholders will vote on the merger on Jan. 6. Medtronic is the world's largest stand-alone medical device maker, with a...

Medical technology company Medtronic Inc said on Nov. 18 that its plan to acquire and adopt the tax domicile of Ireland's Covidien Plc was on track to close in 2015.. High-tech manufacturer Applied Materials Inc plans to buy Japanese rival Tokyo Electron Ltd and reincorporate in the Netherlands. Burger King Worldwide Inc plans to acquire Canadian coffee and...

LONDON/ NEW YORK, Nov 18- Deutsche Bank on Tuesday priced US $1.5 billion of bonds that convert into equity, fortifying its capital strength and its leverage ratio in particular. It was sized at the upper end of the US $1 billion to US $1.5 billion range flagged to investors. Of the rest, around 25% was sold into Asia and the rest into Europe.

Nov 18- Medtronic Inc posted a quarterly profit that was in line with analyst expectations, helped by sales of new heart devices, and said its $42.9 billion purchase of hospital products maker Covidien Plc remains on track to close early next year. But Medtronic executives said they remain fully committed to buying Dublin- based Covidien and are focused on...

Oct 15- Another proposed U.S. corporate tax "inversion" deal collapsed on Friday when Irish food group Fyffes Plc and larger U.S. rival Chiquita Brands International Inc called off an agreement to combine. It was the fourth such deal to unravel since the Treasury Department on Sept. 22 cracked down on inversions, deals in which a U.S. company acquires or sets up a...

Oct 15- Major U.S. drugmaker AbbVie Inc said on Wednesday it was reconsidering a $55 billion bid for Ireland's Shire Plc, marking a setback for "inversion" deals in which U.S. companies reincorporate abroad to cut tax costs. Steris Corp said on Monday it has offered to buy Britain's Synergy Health Plc for about $1.9 billion in a deal that would shift Steris' tax...

Oct 5- Medical equipment supplier Becton Dickinson& Co has agreed to buy CareFusion Corp, a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcare sector deal. Becton said on Sunday it would pay a total of $58.00 a share- $49.00 in cash and 0.0777 of a share of Becton Dickinson- for...

NEW YORK, Oct 3- Covidien Plc and Medtronic Inc both rallied on Friday, with the names moving on heavy volume after Medtronic affirmed its commitment to buy Dublin- based Covidien. Medtronic did change the structure of the deal, saying it would use $16 billion in debt rather than cash held overseas, reacting to changes made by U.S. tax authorities to cut the benefits...

Oct 3- U.S. medical equipment maker Medtronic Inc said it would still buy Covidien Plc but would use $16 billion in debt rather than cash held overseas, reacting to new U.S. Medtronic stock rose 3.6 percent to $65.06, while Covidien gained 5.6 percent to $93.78. Medtronic in June announced plans to buy Ireland's Covidien for cash and stock worth $43 billion.

Oct 3- U.S. medical equipment maker Medtronic Inc said it would still buy Covidien Plc but will use $16 billion in debt rather than cash held overseas, reacting to changes made by U.S. tax authorities to cut the benefits of such "inversion deals." Medtronic in June announced plans to buy Ireland's Covidien for cash and stock worth $43 billion. Medtronic said on Friday...

NEW YORK, Oct 3- Salix Pharmaceuticals Ltd, citing a "changed political environment," said on Friday it had scrapped a deal with Italy's Cosmo Pharmaceuticals SpA that would have allowed it to shift its tax base from the United States to Europe. In recent months, Salix has also been pursued by Allergan Inc as the Botox maker seeks to fend off a $53 billion hostile...